Correlation Between Coya Therapeutics, and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Coya Therapeutics, and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Inovio Pharmaceuticals.
Diversification Opportunities for Coya Therapeutics, and Inovio Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Coya and Inovio is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Inovio Pharmaceuticals
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 0.84 times more return on investment than Inovio Pharmaceuticals. However, Coya Therapeutics, Common is 1.19 times less risky than Inovio Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 457.00 in Coya Therapeutics, Common on September 6, 2024 and sell it today you would earn a total of 152.00 from holding Coya Therapeutics, Common or generate 33.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 98.38% |
Values | Daily Returns |
Coya Therapeutics, Common vs. Inovio Pharmaceuticals
Performance |
Timeline |
Coya Therapeutics, Common |
Inovio Pharmaceuticals |
Coya Therapeutics, and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Coya Therapeutics, and Inovio Pharmaceuticals
The main advantage of trading using opposite Coya Therapeutics, and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |